welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications. Academic scholarships of up to $5,000 will be awarded to up to 20 individuals chosen by an independent committee of Duchenne community members based on an applicant’s community involvement, personal essay and recommendation letter. The Route 79 program is designed to help students with Duchenne pursue their post-secondary educational goals.
rareRelated
-
Duchenne Muscular Dystrophy Research TermsAdeno-Associated Viral (AAV) Adeno-asso...
-
What are the TREAT-NMD Global Registries?New therapeutic strategies for neuromusc...
-
Sue Fletcher, PhD, BSc (Hons)Sue Fletcher is the Professor and Direct...
-
Tiffany CookTiffany Cook joined CureDuchenne in June...
-
Women in the City of Good Neighbors’ Sheds Light on Duchenne Muscular Dystrophy"You don't want that for your child. Eve...
-
Craig Teen With Muscular Dystrophy Inducted as Honorary FirefighterNearly 10 years ago, Craig’s JP Price ...
-
Suspicion of Duchenne Muscular Dystrophy (DMD) – Next Steps for Diagnosishttps://www.youtube.com/watch?v=9jjtyizu...
